teva pharmaceutical-sp adr
Transactions by TEVA PHARMACEUTICAL-SP ADR (TEVA) in the last 6 months
Teva Pharmaceutical Industries Limited (NYSE:TEVA) entered into a definitive agreement to acquire Labrys Biologics, Inc. from venBio LLC, Canaan Partners, InterWest Partners LLC, Sofinnova Ventures, Inc. and other investors for approximately $830 million on June 3, 2014. Under the terms of the agreement, Teva will acquire Labrys for $200 million in upfront payment in cash at closing as well as up to $625 million in contingent payments upon achievement of certain pre-launch ...
InterWest Partners LLC
Sofinnova Ventures, Inc.
A global pharmaceutical company made a non-binding proposal to acquire Gamida Cell Ltd. from a group of sellers on March 7, 2014. The group of sellers include Elbit Medical Technologies Ltd. (TASE:EMTC), Clal Biotechnology Industries (TASE:CBI), Amgen Ventures, Israel Healthcare Ventures, Teva Pharmaceutical Industries Limited, Auriga Partners, Denali Ventures LLC and other shareholders. The proposed consideration for such purchase is expected to include a payment of ...
Clal Biotechnology Industries Ltd.
Denali Ventures LLC
Elbit Medical Technologies Ltd.
Israel Healthcare Ventures
Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited (NYSE:TEVA) signed an agreement to acquire 96% stake in Andromeda Biotech Ltd. from Clal Biotechnology Industries (TASE:CBI) for $72 million on February 24, 2014. The purchase price will be paid in future based on revenue milestones acheived by Andromeda Biotech Ltd.
Phillip Frost sold 0.02% stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) for $7 million during 2013. Phillip Frost sold 0.17 million shares. Following the sales, Phillip Frost owns 14.42 million shares of Teva.
Capital Research and Management Company and Capital Research Global acquired a 5.6% stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA) on December 31, 2013. Capital Research & Management Co. beneficially owned 52.57 million Teva shares. Capital Research Global owns 48.43 million Teva shares.
|Abbott Laboratories||$43.04 USD||+0.08|
|AbbVie Inc||$54.10 USD||+0.10|
|Amgen Inc||$120.72 USD||+1.69|
|Baxter International Inc||$76.95 USD||+0.84|
|Eli Lilly & Co||$63.92 USD||+0.28|
|View Industry Companies|